Design and development of novel bioadhesive niosomal formulation for the transcorneal delivery of anti-infective agent: In-vitro and ex-vivo investigations

Lee, 1979, Mechanistic and quantitative evaluation of precorneal pilocarpine disposition in albino rabbits, J Pharm Sci, 68, 673, 10.1002/jps.2600680606 Chrai, 1973, Lacrimal and instilled fluid dynamics in rabbit eyes, J Pharm Sci, 62, 1112, 10.1002/jps.2600620712 Greaves, 1993, Assessment of the precorneal residence of an ophthalmic ointment in healthy subjects, Br J Clin Pharmacol, 35, 188 Mazor, 1979, Piloplex, a new long-acting pilocarpine polymer salt. B: comparative study of the visual effects of pilocarpine and piloplex eye drops, Br J Ophthalmol, 63, 48, 10.1136/bjo.63.1.48 Loftsson, 2002, Cyclodextrins in eye drop formulations: enhanced topical delivery of corticosteroids to the eye, Acta Ophthalmol Scand, 80, 144, 10.1034/j.1600-0420.2002.800205.x Verma, 2013, Development, in vitro and in vivo characterization of Eudragit RL 100 nanoparticles for improved ocular bioavailability of acetazolamide, Drug Deliv, 20, 269, 10.3109/10717544.2013.834417 Loftsson, 1994, Topically effective ocular hypotensive acetazolamide and ethoxyzolamide formulations in rabbits, J Pharm Pharmacol, 46, 503, 10.1111/j.2042-7158.1994.tb03835.x Hwang, 1989, Collagen shield enhancement of topical dexamethasone penetration, Archives Ophthalmol, 107, 1375, 10.1001/archopht.1989.01070020445052 Nagarsenker, 1999, Preparation and evaluation of liposomal formulations of tropicamide for ocular delivery, Int J Pharm, 190, 63, 10.1016/S0378-5173(99)00265-3 Lou, 2014, Optimization and evaluation of a thermoresponsive ophthalmic in situ gel containing curcumin-loaded albumin nanoparticles, Int J Nanomedicine, 9, 2517 Shen, 2014, Formulation and evaluation of cyclosporin A emulgel for ocular delivery, Drug Deliv, 1, 10.3109/10717544.2014.929756 Tieppo, 2014, Analysis of release kinetics of ocular therapeutics from drug releasing contact lenses: best methods and practices to advance the field. Contact lens & anterior eye, J Br Contact Lens Assoc, 37, 305, 10.1016/j.clae.2014.04.005 Ahuja, 2008, Effect of formulation parameters on corneal permeability of ofloxacin, Sci Pharm, 76, 505, 10.3797/scipharm.0804-22 Bendas, 2007, Enhanced transdermal delivery of salbutamol sulfate via ethosomes, AAPS PharmSciTech, 8, 213, 10.1208/pt0804107 El Maghraby, 2001, Skin delivery of 5-fluorouracil from ultradeformable and standard liposomes in-vitro, J Pharm Pharmacol, 53, 1069, 10.1211/0022357011776450 Motwani, 2008, Chitosan–sodium alginate nanoparticles as submicroscopic reservoirs for ocular delivery: formulation, optimisation and in vitro characterisation, Eur J Pharm Biopharm, 68, 513 Bachhav, 2009, Microemulsion-based vaginal gel of clotrimazole: formulation, in vitro evaluation, and stability studies, AAPS PharmSciTech, 10, 476, 10.1208/s12249-009-9233-2 Monti, 2003, Effect of iontophoresis on transcorneal permeation 'in vitro' of two beta-blocking agents, and on corneal hydration, Int J Pharm, 250, 423, 10.1016/S0378-5173(02)00557-4 Tamizharasi, 2009, Development and characterization of niosomal drug delivery of gliclazide, J Young Pharm, 1, 205 Kaur, 2010, Improved ocular absorption kinetics of timolol maleate loaded into a bioadhesive niosomal delivery system, Graefe's Archive Clin Exp Ophthalmol, 248, 1467, 10.1007/s00417-010-1383-0 Khan, 2014, Novel carbopol-based transfersomal gel of 5-fluorouracil for skin cancer treatment: in vitro characterization and in vivo study, Drug Deliv, 1, 10.3109/10717544.2014.902146 Maurice, 1971, The tonicity of an eye drop and its dilution by tears, Exp Eye Res, 11, 30, 10.1016/S0014-4835(71)80061-1 Negi, 2013, Nano scale self-emulsifying oil based carrier system for improved oral bioavailability of camptothecin derivative by P-Glycoprotein modulation. Colloids and surfaces B, Biointerfaces, 111C, 346, 10.1016/j.colsurfb.2013.06.001 Mohan Negi, 2013, Development of ethanolic nano vesicles of tenoxicam, investigation of transdermal penetration efficiency and histological safety comparison with common penetration enhancers, Nanosci Nanotechnol Lett, 5, 600, 10.1166/nnl.2013.1593